BUBR1 EXPRESSION IN ORAL SQUAMOUS CELL CARCINOMA AND ITS RELATIONSHIP TO TUMOR STAGE AND SURVIVAL

被引：16
|
作者：
Rizzardi, Clara [1 ]
Torelli, Lucio [2 ]
Barresi, Elena [1 ]
Schneider, Manuela [3 ]
Canzonieri, Vincenzo [4 ]
Biasotto, Matteo [5 ]
Di Lenarda, Roberto [5 ]
Melato, Mauro [1 ]
机构：
[1] Univ Trieste, Dept Pathol & Forens Med, Trieste, Italy
[2] Univ Trieste, Dept Math & Comp Sci, Trieste, Italy
[3] Azienda Serv Sanit 2 Isontina, Unit Pathol, Gorizia, Italy
[4] IRCCS, Ist Nazl Tumori, Ctr Riferimento Oncol, Aviano, Italy
[5] Univ Trieste, Dept Biomed, Unit Dent & Stomatol, Trieste, Italy
来源：
HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK | 2011年 / 33卷 / 05期
关键词：
squamous cell carcinoma; oral; prognostic factor; spindle checkpoint; BUBR1; MITOTIC CHECKPOINT GENES; SPINDLE ASSEMBLY CHECKPOINT; CHROMOSOMAL INSTABILITY; CANCER-CELLS; HEPATOCELLULAR-CARCINOMA; BLADDER-CANCER; GASTRIC-CANCER; LUNG-CANCER; OVEREXPRESSION; ANEUPLOIDY;
D O I：
10.1002/hed.21532
中图分类号：
R76 [耳鼻咽喉科学];
学科分类号：
100213 ;
摘要：
Background. Defects in the mitotic spindle checkpoint have been proposed to contribute to the chromosomal instability observed in human cancers, including oral squamous cell carcinoma (OSCC). BUBR1 is a key component of the spindle checkpoint, whose role in oral carcinogenesis still needs to be clarified. Methods. We have analyzed the expression of BUBR1 in 49 cases of OSCC by immunohistochemistry and compared the findings with clinicopathologic parameters, proliferative activity, and DNA ploidy. Results. BUBR1 was overexpressed in 11 cases (22.4%). Tumors with overexpression of BUBR1 were associated with a less advanced pathologic stage (p = .05) and showed longer survival periods (p = .38) but shorter recurrence-free survival periods (p = .13) than those without it. Conclusions. Our data imply the possibility that BUBR1 may be involved in the progression of OSCC, and suggest that BUBR1 may be a promising prognostic marker in patients with OSCC. (C) 2010 Wiley Periodicals, Inc. Head Neck 33: 727-733, 2011
引用
收藏
页码：727 / 733
页数：7
相关论文
共 50 条
  • [1] Expression of BUBR1 in human oral potentially malignant disorders and squamous cell carcinoma
    Hsieh, Pi-Chuan
    Chen, Yuk-Kwan
    Tsai, Kun-Bow
    Shieh, Tien-Yu
    Chang, Yong-Yuan
    Chang, Jan-Gowth
    Wu, Hsin-Lung
    Lin, Sheng-Fung
    ORAL SURGERY ORAL MEDICINE ORAL PATHOLOGY ORAL RADIOLOGY AND ENDODONTOLOGY, 2010, 109 (02): : 257 - 267
  • [2] BUBR1 as a Prognostic Biomarker in Canine Oral Squamous Cell Carcinoma
    Delgado, Leonor
    Monteiro, Luis
    Silva, Patricia
    Bousbaa, Hassan
    Garcez, Fernanda
    Silva, Joao
    Brilhante-Simoes, Paula
    Pires, Isabel
    Prada, Justina
    ANIMALS, 2022, 12 (22):
  • [3] MAD2 Expression in Oral Squamous Cell Carcinoma and its Relationship to Tumor Grade and Proliferation
    Rizzardi, Clara
    Torelli, Lucio
    Schneider, Manuela
    Giudici, Fabiola
    Zandona', Lorenzo
    Biasotto, Matteo
    Di Lenarda, Roberto
    Melato, Mauro
    ANTICANCER RESEARCH, 2014, 34 (12) : 7021 - 7027
  • [4] BUBR1 expression in benign oral lesions and squamous cell carcinomas: Correlation with human papillomavirus
    Lira, Regia C. P.
    Miranda, Fabiana A.
    Guimaraes, Marcia C. M.
    Simoes, Renata T.
    Donadi, Eduardo A.
    Soares, Christiane P.
    Soares, Edson G.
    ONCOLOGY REPORTS, 2010, 23 (04) : 1027 - 1036
  • [5] Abnormal expression of the mitotic checkpoint protein BubR1 contributes to the anti-microtubule drug resistance of esophageal squamous cell carcinoma cells
    Hu, Min
    Liu, Qingsong
    Song, Peipei
    Zhan, Xiaoqin
    Luo, Min
    Liu, Chen
    Yang, Dandan
    Cai, Yan
    Zhang, Fan
    Jiang, Fengbing
    Zhang, Yan
    Tang, Min
    Zuo, Guowei
    Zhou, Lan
    Luo, Jinyong
    Shi, Qiong
    Weng, Yaguang
    ONCOLOGY REPORTS, 2013, 29 (01) : 185 - 192
  • [6] T regulatory cell markers in oral squamous cell carcinoma: Relationship with survival and tumor aggressiveness
    Moreira, Geane
    Fulgencio, Livia Bonfim
    De Mendonca, Elismauro Francisco
    Leles, Claudio Rodrigues
    Batista, Aline Carvalho
    Da Silva, Tarcilia Aparecida
    ONCOLOGY LETTERS, 2010, 1 (01) : 127 - 132
  • [7] BUBR1 overexpression predicts disease-specific survival after nephroureterectomy in patients with upper tract urothelial carcinoma
    Yamamoto, Yoshiaki
    Oga, Atsunori
    Akao, Jumpei
    Misumi, Taku
    Fuji, Nakanori
    Kobayashi, Keita
    Kawai, Yoshihisa
    Inoue, Ryo
    Hirata, Hiroshi
    Matsumoto, Hiroaki
    Nagao, Kazuhiro
    Sakano, Shigeru
    Matsuyama, Hideyasu
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2016, 46 (08) : 754 - 761
  • [8] Expression of Wilms' tumor 1 (WT1) in oral squamous cell carcinoma
    Mikami, Toshinari
    Hada, Tomohiro
    Chosa, Naoyuki
    Ishisaki, Akira
    Mizuki, Harumi
    Takeda, Yasunori
    JOURNAL OF ORAL PATHOLOGY & MEDICINE, 2013, 42 (02) : 133 - 139
  • [9] BubR1 is frequently repressed in acute myeloid leukemia and its re-expression sensitizes cells to antimitotic therapy
    Schnerch, Dominik
    Schmidts, Andrea
    Folio, Marie
    Udi, Josefina
    Felthaus, Julia
    Pfeifer, Dietmar
    Engelhardt, Monika
    Waesch, Ralph
    HAEMATOLOGICA, 2013, 98 (12) : 1886 - 1895
  • [10] Comprehensive study on the prognostic role of osteopontin expression in oral squamous cell carcinoma
    Chien, Chih-Yen
    Su, Chih-Ying
    Chuang, Hui-Ching
    Fang, Fu-Min
    Huang, Hsuan-Ying
    Chen, Chang-Han
    Chen, Ching-Mei
    Huang, Chao-Cheng
    ORAL ONCOLOGY, 2009, 45 (09) : 798 - 802
12345